CWC
EBS icon

Carolinas Wealth Consulting’s Emergent Biosolutions EBS Stock Holding History

Carolinas Wealth Consulting’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-54
Closed -$2K – 891
2022
Q2 		$2K Hold
54
– – ﹤0.01% 754
2022
Q1 		$2K Hold
54
– – ﹤0.01% 791
2021
Q4 		$2K Sell
54
-2
-4% -$90 ﹤0.01% 820
2021
Q3 		$3K Hold
56
– – ﹤0.01% 735
2021
Q2 		$4K Buy
56
+22
+65% +$1.41K ﹤0.01% 720
2021
Q1 		$3K Sell
34
-3
-8% -$307 ﹤0.01% 765
2020
Q4 		$3K Sell
37
-27
-42% -$2.48K ﹤0.01% 696
2020
Q3 		$7K Buy
+64
New +$6.9K ﹤0.01% 524

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Carolinas Wealth Consulting's EBS Position: Q3 2022 in Review

Carolinas Wealth Consulting sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 54 shares — an estimated $2K sold.

Carolinas Wealth Consulting first reported a position in EBS in Q3 2020 and held it in 8 quarters. The position peaked at $7K in Q3 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Carolinas Wealth Consulting reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 54 Emergent Biosolutions shares in Q3 2022, an estimated $2K.
  • Carolinas Wealth Consulting first reported a position in Emergent Biosolutions in Q3 2020 and held it in 8 quarters.
  • Carolinas Wealth Consulting's Emergent Biosolutions position peaked at $7K in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Carolinas Wealth Consulting's 13F filing for Q3 2022, filed 14 Nov 2022.